The Applicant Assistance Program helps small businesses apply for Phase I Small Business Innovation Research (SBIR)/Small Business Technology Transfer funding. Selected small businesses can participate in the program at no cost. Learn more: http://spr.ly/6048brcRa
National Cancer Institute (NCI)
Government Administration
Bethesda, MD 287,510 followers
The National Cancer Institute, part of the National Institutes of Health, is the lead federal agency for cancer research
About us
The National Cancer Institute (NCI), part of the National Institutes of Health, is the lead federal agency for cancer research. For more information about NCI, visit us at www.cancer.gov. Privacy policy: https://www.cancer.gov/policies/privacy-security Engagement ≠ endorsement
- Website
- http://www.cancer.gov
External link for National Cancer Institute (NCI)
- Industry
- Government Administration
- Company size
- 1,001-5,000 employees
- Headquarters
- Bethesda, MD
- Type
- Government Agency
- Specialties
- cancer, cancer research, cancer training, cancer research grants, cancer resources, cancer information, and cancer research funding
Locations
- Primary
9000 Rockville Pike
Bethesda, MD 20892, US
-
9609 Medical Center Drive
Rockville, MD 20850, US
-
Ft. Detrick U.S. Army Facility
Frederick, MD, US
Employees at National Cancer Institute (NCI)
Updates
-
MEDIA ADVISORY: An international team of researchers, led by NCI scientists, has identified 50 new areas across the human genome that are associated with the risk of developing kidney cancer. The study includes participants of diverse ancestry and offers insights into the role genetics may play in the development of a rare subtype of the disease. http://spr.ly/6041bvB93
-
NCI's Childhood Cancer Data Initiative plans to announce a funding opportunity for organizations that can conduct molecular profiling to improve the diagnosis and treatment of childhood and adolescent and young adult (AYA) cancers. Look out for the announcement. Here’s a preview: http://spr.ly/6047bv5q5
-
What are environmental carcinogens, and how do they impact cancer risk? Any substance that causes cancer is known as a carcinogen. But simply because a substance has been designated as a carcinogen does not mean that the substance will necessarily cause cancer. http://spr.ly/6040b5uWa #CancerPreventionandEarlyDetectionMonth
-
Researchers at the Frederick National Laboratory for Cancer Research identified a vitamin A derivative (retinoid) that when combined with a standard immunotherapy will shrink otherwise checkpoint-resistant lung tumors in mice. This is a potential step toward human clinical trials to improve lung cancer treatment. http://spr.ly/6044bv5SY
Specific retinoid shrinks immune checkpoint-resistant lung cancers in mice | Frederick National Laboratory
frederick.cancer.gov
-
The Oral Cancer Survival Calculator can give survival estimates to people who have recently been diagnosed with oral cancer (also known as oral cavity cancer) and who are looking for information. For best results, this tool should be used with your clinician. http://spr.ly/6044bOpGj
-
Multi-cancer detection tests look for biological signals, or biomarkers, that are released by cancer cells or induced by their presence. This article co-written by NCI researchers explores questions about these tests: http://spr.ly/6045bOpKL NCI Division of Cancer Prevention American Cancer Society Journals
-
A new view of cell division may change the way scientists think about how some cancer drugs affect cells. Learn more about this work from NCI Center for Cancer Research: http://spr.ly/6043bOpHc
No Point of No Return
-
Cancer prevention is action taken to lower the chance of getting cancer. #CancerPreventionandEarlyDetectionMonth
This content isn’t available here
Access this content and more in the LinkedIn app
-
Most men in the U.S. with prostate cancer will still be alive 15 years after their diagnosis. But treatments for the disease can have side effects, such as bladder and bowel problems, and difficulty with sexual functioning. Learn more: http://spr.ly/6048bOnCQ
Comparing side effects after prostate cancer treatment
nih.gov